Gargoyle Investment Advisor L.L.C. maintained its position in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,457 shares of the medical technology company’s stock at the end of the second quarter. Hill-Rom Holdings comprises about 1.5% of Gargoyle Investment Advisor L.L.C.’s holdings, making the stock its 6th largest position. Gargoyle Investment Advisor L.L.C. owned 0.07% of Hill-Rom Holdings worth $3,858,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Hill-Rom Holdings by 13,535.4% in the first quarter. BlackRock Inc. now owns 5,067,064 shares of the medical technology company’s stock worth $357,736,000 after buying an additional 5,029,903 shares during the period. Vanguard Group Inc. increased its position in shares of Hill-Rom Holdings by 17.5% in the first quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock worth $405,066,000 after buying an additional 853,385 shares during the period. Rothschild Asset Management Inc. purchased a new position in shares of Hill-Rom Holdings during the first quarter worth approximately $49,880,000. Nationwide Fund Advisors increased its position in shares of Hill-Rom Holdings by 135.8% in the first quarter. Nationwide Fund Advisors now owns 387,218 shares of the medical technology company’s stock worth $27,338,000 after buying an additional 223,018 shares during the period. Finally, BTIM Corp. purchased a new position in shares of Hill-Rom Holdings during the first quarter worth approximately $14,935,000. Hedge funds and other institutional investors own 84.00% of the company’s stock.
Shares of Hill-Rom Holdings Inc (HRC) opened at 73.72 on Friday. The firm has a market cap of $4.86 billion, a PE ratio of 42.96 and a beta of 1.22. The firm has a 50 day moving average price of $79.48 and a 200-day moving average price of $72.76. Hill-Rom Holdings Inc has a 12 month low of $50.50 and a 12 month high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $689.10 million for the quarter, compared to analysts’ expectations of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The company’s revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.81 earnings per share. On average, analysts predict that Hill-Rom Holdings Inc will post $3.82 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.98%. Hill-Rom Holdings’s payout ratio is presently 41.62%.
COPYRIGHT VIOLATION WARNING: “Hill-Rom Holdings Inc (HRC) is Gargoyle Investment Advisor L.L.C.’s 6th Largest Position” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.com-unik.info/2017/08/13/hill-rom-holdings-inc-hrc-is-gargoyle-investment-advisor-l-l-c-s-6th-largest-position.html.
A number of research analysts have commented on HRC shares. Barclays PLC boosted their target price on Hill-Rom Holdings from $70.00 to $75.00 and gave the company an “overweight” rating in a research note on Wednesday, April 19th. ValuEngine raised Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research cut Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday, May 31st. Morgan Stanley boosted their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Friday, June 30th. Finally, Stifel Nicolaus boosted their price target on Hill-Rom Holdings from $70.00 to $84.00 and gave the stock a “buy” rating in a research report on Monday, May 1st. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $88.17.
In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of the business’s stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $72.30, for a total transaction of $150,239.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the sale, the senior vice president now directly owns 28,988 shares in the company, valued at approximately $2,279,036.56. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
Hill-Rom Holdings Company Profile
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).
What are top analysts saying about Hill-Rom Holdings Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Hill-Rom Holdings Inc and related companies.